Targeting HDAC6 to reduce the aggressiveness of metastatic breast cancer in immunotherapy

被引：1
|
作者：
Banik, Debarati [1 ]
Hadley, Melissa [1 ]
Palmer, Erica [1 ]
Gallub, Vincent [1 ]
Sotomayor, Eduardo [1 ]
Kozikowski, Alan [2 ]
Villagra, Alejandro [1 ]
机构：
[1] George Washington Univ, Hyattsville, MD USA
[2] Starwise, Madison, WI USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-48
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
48
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Histone Deacetylase 6 (HDAC6) Influences T-Cell Activation and Survival: Implications For Cancer Immunotherapy
    Laino, Andressa Sodre
    Woods, David M.
    Cheng, Fengdong
    Wang, Hongwei
    Sotomayor, Eduardo M.
    BLOOD, 2013, 122 (21)
  • [22] Dihydropyrazole-Carbohydrazide Derivatives with Dual Activity as Antioxidant and Anti-Proliferative Drugs on Breast Cancer Targeting the HDAC6
    Balbuena-Rebolledo, Irving
    Rivera-Antonio, Astrid M.
    Sixto-Lopez, Yudibeth
    Correa-Basurto, Jose
    Rosales-Hernandez, Martha C.
    Elena Mendieta-Wejebe, Jessica
    Martinez-Martinez, Francisco J.
    Maria Olivares-Corichi, Ivonne
    Ruben Garcia-Sanchez, Jose
    Alberto Guevara-Salazar, Juan
    Bello, Martiniano
    Padilla-Martinez, Itzia I.
    PHARMACEUTICALS, 2022, 15 (06)
  • [23] Enhancing the effect of immunotherapy by inhibiting tumor promoting effect of HDAC6
    Banik, Debarati
    Beaty, Melissa
    Palmer, Erical
    Hernandez, Maria Del Mar Gracia
    Noonepalle, Satish K.
    Vembu, Prathima
    Kozikowski, Alan P.
    Villagra, Alejandro
    CANCER RESEARCH, 2019, 79 (13)
  • [24] Design and synthesis of novel HDAC6 inhibitor dimer as HDAC6 degrader for cancer treatment by palladium catalysed dimerisation
    Lin, Ching
    Hsu, Jui-Ling
    Hsu, Yu-Tung
    Fan, Kuo-Chen
    Wu, Sian-Siou
    Lin, Miao-Hsia
    Guh, Jih-Hwa
    Yu, Chao-Wu
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2025, 40 (01)
  • [25] The immunohistochemical expression and potential prognostic value of HDAC6 and AR in invasive breast cancer
    Li, Congying
    Cao, Lu
    Xu, Cong
    Liu, Fang
    Xiang, Guomin
    Liu, Xiaozhen
    Jiao, Jiao
    Niu, Yun
    HUMAN PATHOLOGY, 2018, 75 : 16 - 25
  • [26] Targeting HDAC6 to Overcome Autophagy-Promoted Anti-Cancer Drug Resistance
    Jo, Hyein
    Shim, Kyeonghee
    Jeoung, Dooil
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [27] Targeting the aggresome with an HDAC6 inhibitor in combination with velcade for myeloma therapy
    不详
    CANCER BIOLOGY & THERAPY, 2005, 4 (07) : I - I
  • [28] Unique HDAC6 inhibitors targeting Hsp90 complexes
    Chou, C. James
    Inks, Elizabeth S.
    Josey, Benjamin J.
    Jesinkey, Sean R.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [29] Anti-metastatic activity of MPTOG211, a novel HDAC6 inhibitor, in human breast cancer cells in vitro and in vivo
    Hsieh, Yi-Ling
    Tu, Huang-Ju
    Pan, Shiow-Lin
    Liou, Jing-Ping
    Yang, Chia-Ron
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2019, 1866 (06): : 992 - 1003
  • [30] Targeting prostate cancer with compounds possessing dual activity as androgen receptor antagonists and HDAC6 inhibitors
    Jadhavar, Pradeep S.
    Ramachandran, Sreekanth A.
    Riquelme, Eduardo
    Gupta, Ashu
    Quinn, Kevin P.
    Shivakumar, Devleena
    Ray, Soumya
    Zende, Dnyaneshwar
    Nayak, Anjan K.
    Miglani, Sandeep K.
    Sathe, Balaji D.
    Raja, Mohd.
    Farias, Olivia
    Alfaro, Ivan
    Belmar, Sebastian
    Guerrero, Javier
    Bernales, Sebastian
    Chakravarty, Sarvajit
    Hung, David T.
    Lindquist, Jeffrey N.
    Rai, Roopa
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (21) : 5222 - 5228
12345